EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Benzimidazole scaffold as a potent anticancer agent with different mechanisms of action (2016–2023)

Fatma Fouad Hagar, Samar H Abbas, Eman Atef, Dalia Abdelhamid, Mohamed Abdel-Aziz

Molecular Diversity · 2025-04 · 29 (2) · 1821-1849

DOI: 10.1007/s11030-024-10907-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Diversity, online erschienen am 20.07.2024. Verfasst von Fatma Fouad Hagar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal Chemistry Department, Faculty of Pharmacy, Minia University, Minia, Egypt. Hauptthemen laut MEDLINE: Benzimidazoles, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Minia University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Benzimidazole scaffolds have potent anticancer activity due to their structure similarity to nucleoside. In addition, benzimidazoles could function as hydrogen donors or acceptors and bind to different drug targets that participate in cancer progression. The literature had many anticancer agents containing benzimidazole cores that gained much interest. Provoked by our endless interest in benzimidazoles as anticancer agents, we summarized the successful trials of the benzimidazole scaffolds in this concern. Moreover, we discuss the substantial opportunities in cancer treatment using benzimidazole-based drugs that may direct medicinal chemists for a compelling future design of more active chemotherapeutic agents with potential clinical applications. The uniqueness of this work lies in the highlighted benzimidazole scaffold hybridization with different molecules and benzimidazole-metal complexes, detailed mechanisms of action, and the IC 50 of the developed compounds determined by different laboratories after 2015.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzimidazolesAntineoplastic AgentsNeoplasmsHumansStructure-Activity RelationshipAnimals

Stichwörter der Autor:innen

AnticancerBenzimidazoleHybridMechanism of actionMetal complex

Substanzen

BenzimidazolesAntineoplastic Agents

Autor:innen und Institutionen

  • Medicinal Chemistry Department, Faculty of Pharmacy, Minia University, Minia, Egypt.
  • Medicinal Chemistry Department, Faculty of Pharmacy, Minia University, Minia, Egypt. samar_hafez@mu.edu.eg.
  • College of Pharmacy, West Coast University, Los Angeles, CA, USA.
  • Medicinal Chemistry Department, Faculty of Pharmacy, Minia University, Minia, Egypt. dalia_abdelhameed@mu.edu.e.g.eg.
  • Raabe College of Pharmacy, Ohio Northern University, Ohio, USA. dalia_abdelhameed@mu.edu.e.g.eg.

Förderung

  • Minia University

Zitieren

APA

Hagar, F. F., Abbas, S. H., Atef, E., Abdelhamid, D., & Abdel-Aziz, M. (2025). Benzimidazole scaffold as a potent anticancer agent with different mechanisms of action (2016–2023). Molecular Diversity, 29(2), 1821-1849. https://doi.org/10.1007/s11030-024-10907-8

Vancouver

Hagar FF, Abbas SH, Atef E, Abdelhamid D, Abdel-Aziz M. Benzimidazole scaffold as a potent anticancer agent with different mechanisms of action (2016–2023). Molecular Diversity. 2025;29(2):1821-1849. doi:10.1007/s11030-024-10907-8

BibTeX
@article{Hagar2025,
  author = {Hagar, Fatma Fouad and Abbas, Samar H and Atef, Eman and Abdelhamid, Dalia and Abdel-Aziz, Mohamed},
  title = {Benzimidazole scaffold as a potent anticancer agent with different mechanisms of action (2016–2023)},
  journal = {Molecular Diversity},
  year = {2025},
  volume = {29},
  number = {2},
  pages = {1821--1849},
  doi = {10.1007/s11030-024-10907-8}
}
Kostenlos starten →